S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

CDTX Cidara Therapeutics Inc

12.26

0.45 (3.81%)

Last Updated: 03:47:35

Delayed by 15 minutes

Cidara gains on dosing milestone in early-stage trial for flu candidate

To read the full story on Seeking Alpha, click here.

Cidara Therapeutics (NASDAQ:CDTX)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Cidara Therapeutics Charts.

Cidara Therapeutics (NASDAQ:CDTX)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Cidara Therapeutics Charts.

Cidara Therapeutics Inc News

Form DEF 14A - Other definitive proxy statements
Tuesday 5 March 2024 (2 months ago) • Edgar (US Regulatory)

Form PRE 14A - Other preliminary proxy statements
Saturday 24 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Saturday 10 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 22 December 2023 (4 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Saturday 18 November 2023 (5 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 17 November 2023 (6 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 3 November 2023 (6 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Friday 3 November 2023 (6 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Saturday 14 October 2023 (7 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 22 September 2023 (7 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 14 September 2023 (8 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 14 September 2023 (8 months ago) • Edgar (US Regulatory)

More Cidara Therapeutics Inc News Articles

Verizon Communications

Australian SE All Ordina...

Westpac Banking

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions